REATA PHARMACEUTICALS INC Income (Loss) from Continuing Operations, Per Basic Share
REATA PHARMACEUTICALS INC reported Income (Loss) from Continuing Operations, Per Basic Share of -$0.86 per share for the 3-month period ending 2018-12-31, per its 10-K filed 2020-02-19.
Discontinued › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsPerBasicShare · last filed 2020-02-19
- REATA PHARMACEUTICALS INC income (loss) from continuing operations, per basic share for the quarter ending 2018-12-31 was -$0.86.
- REATA PHARMACEUTICALS INC income (loss) from continuing operations, per basic share for the quarter ending 2018-09-30 was -$1.07.
- REATA PHARMACEUTICALS INC income (loss) from continuing operations, per basic share for the quarter ending 2018-06-30 was -$1.08.
- REATA PHARMACEUTICALS INC income (loss) from continuing operations, per basic share for the quarter ending 2018-03-31 was $0.16.
| Period end | Income (Loss) from Continuing Operations, Per Basic Share 3 month |
|---|---|
| 2018-12-31 | -$0.86 10-K · filed 2020-02-19 |
| 2018-09-30 | -$1.07 10-K · filed 2020-02-19 |
| 2018-06-30 | -$1.08 10-K · filed 2020-02-19 |
| 2018-03-31 | $0.16 10-K · filed 2020-02-19 |